BCL9-2 Antibody (3B9C1) - BSA Free

Western Blot: BCL9-2 Antibody (3B9C1) [NBP2-61823] - Analysis using BCL9L mAb against human BCL9L (AA: 606-751) recombinant protein. (Expected MW is 41.9 kDa)

Immunohistochemistry: BCL9-2 Antibody (3B9C1) [NBP2-61823] - Analysis of paraffin-embedded cervical cancer tissues using BCL9L mouse mAb with DAB staining.

Western Blot: BCL9-2 Antibody (3B9C1) [NBP2-61823] - Analysis using BCL9L mAb against HEK293 (1) and BCL9L (AA: 606-751)-hIgGFc transfected HEK293 (2) cell lysate.

ELISA: BCL9-2 Antibody (3B9C1) [NBP2-61823] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)

• Reactivity: Hu
• Applications: WB, ELISA, IHC
• Clone: 3B9C1
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Unconjugated
• Format: BSA Free
• Concentration: 1 mg/ml

BCL9-2 Antibody (3B9C1) - BSA Free Summary

• Immunogen: Purified recombinant fragment of human BCL9-2 (AA: 606-751) expressed in E. Coli.
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Mouse
• Gene: BCL9L
• Purity: Protein G purified

Applications/Dilutions

• Dilutions:
  • ELISA 1:100-1:2000
  • Immunohistochemistry 1:10-1:1000
  • Immunohistochemistry-Paraffin 1:200 - 1:1000
  • Western Blot 1:100-1:2000
• Theoretical MW: 157 kDa.
  Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.

Packaging, Storage & Formulations

• Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
• Buffer: PBS
• Preservative: 0.05% Sodium Azide
• Concentration: 1 mg/ml
• Purity: Protein G purified

Alternate Names for BCL9-2 Antibody (3B9C1) - BSA Free

• B-cell CLL/lymphoma 9-like protein
• B-cell CLL/lymphoma 9-like
• B-cell lymphoma 9-like protein
• Bcl92
• Bcl9-2
• BCL9-like protein
• DLNB11
• DLNB11BCL9-2
• nuclear co-factor of beta-catenin signalling
• Protein BCL9-2

Background

BCL9L (B-Cell CLL/Lymphoma 9-Like) is a Protein Coding gene. Among its related pathways are Wnt Signaling Pathways: beta-Catenin-dependent Wnt Signaling and Signaling by Wnt. GO annotations related to this gene include transcription coactivator activity and beta-catenin binding. An important paralog of this gene is BCL9.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: BCL9L